Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Sparian Biosciences Logo
Sparian Biosciences Growth Score
88
CB Rank
44375
Heat Score
66
Sparian Biosciences is a biopharmaceutical company.
Founded
obfuscation
PrivateGrant New York, New York, United States1-10 www.sparianbiosciences.com
Biotechnology
Consulting
Pharmaceutical
Therapeutics
Overview

Sparian Biosciences
Total Funding
obfuscation
Growth Score
88
Heat Score
66

Total Funding
obfuscation
obfuscation
Grant raised
obfuscation
Growth Score88
-1 pts
in past quarter
Heat Score 66
5 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
+2 more milestones
See more interactive data and historical milestones on desktop for the best experience

About Sparian Biosciences

CB Rank
44375
Sparian Biosciences is a biopharmaceutical company.
Founded
obfuscation
PrivateGrant New York, New York, United States1-10 www.sparianbiosciences.com
Biotechnology
Consulting
Pharmaceutical
Therapeutics

Funding Rounds

Grant
OBF
in
obfuscation
Grant
OBF
in
obfuscation

Details

Legal Name Sparian Biosciences, Inc.
Operating Status Active
Company Type For Profit
About the Company
Sparian Biosciences is an early-stage CNS-focused biopharmaceutical firm focusing on creating unique, transformative medicines for the central nervous system. They develop therapeutics targeting the brain through innovative science and novel drug discovery.
Predictions & Insights

Growth Insight

See this Growth Insight
Sparian Biosciences is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Runway Speculation

Products & Services

SBS-1000
An arylepoxamide receptor (AEAr) agonist developed for acute and chronic pain treatment, administered intravenously or subcutaneously.
SBS-147
An oral arylepoxamide receptor (AEAr) agonist for acute and chronic pain, undergoing CMC and IND-enabling studies.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Sparian Biosciences Logo
Grant - Sparian Biosciences
1
obfuscation
National Institute on Drug Abuse (NIDA)Grant
obfuscation
Grant - Sparian Biosciences Logo
Grant - Sparian Biosciences
1
obfuscation
National Institute on Drug Abuse (NIDA)Grant
obfuscation
Grant - Sparian Biosciences Logo
Grant - Sparian Biosciences
1
obfuscation
National Institute on Drug Abuse (NIDA)Grant
obfuscation
Grant - Sparian Biosciences Logo
Grant - Sparian Biosciences
1
obfuscation
National Institute on Drug Abuse (NIDA)Grant
obfuscation
Grant - Sparian Biosciences Logo
Grant - Sparian Biosciences
1
obfuscation
National Institute on Drug Abuse (NIDA)Grant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Sparian Biosciences Logo
Grant - Sparian Biosciences
1
obfuscation
National Institute on Drug Abuse (NIDA)Grant
obfuscation
Grant - Sparian Biosciences Logo
Grant - Sparian Biosciences
1
obfuscation
National Institute on Drug Abuse (NIDA)Grant
obfuscation
Grant - Sparian Biosciences Logo
Grant - Sparian Biosciences
1
obfuscation
National Institute on Drug Abuse (NIDA)Grant
obfuscation
Grant - Sparian Biosciences Logo
Grant - Sparian Biosciences
1
obfuscation
National Institute on Drug Abuse (NIDA)Grant
obfuscation
Grant - Sparian Biosciences Logo
Grant - Sparian Biosciences
1
obfuscation
National Institute on Drug Abuse (NIDA)Grant

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Contacts 4
News

News and Press

News•Apr 13, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 10, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 9, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Nov 15, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

454
121.46%
 in past month

IT Spend

$34.3KThis year, Sparian Biosciences is projected to spend $34.3K on IT, according to Aberdeen.

Active Website Tech Count

2Sparian Biosciences is actively using 2 technologies for its website, according to BuiltWith. These include Common Crawl and  CommonCrawl Top 10m.
Sub-Organizations
Frequently Asked Questions

Where is Sparian Biosciences's headquarters? Sparian Biosciences is located in New York, New York, United States.Who invested in Sparian Biosciences? Sparian Biosciences has 2 investors including National Institute on Drug Abuse (NIDA) and  National Institutes of Health.When was the last funding round for Sparian Biosciences? Sparian Biosciences closed its last funding round on
obfuscation
from a Grant round.Who are Sparian Biosciences's competitors? Alternatives and possible competitors to Sparian Biosciences may include Ensysce Biosciences, Vertex Pharmaceuticals, and  Latigo Biotherapeutics.How much funding has Sparian Biosciences raised to date? Sparian Biosciences has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(2e7868f 1)
|